Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 19 May 2006. doi:10.1136/jcp.2006.038778
Journal of Clinical Pathology 2007;60:273-277
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray

Huachuan Zheng1, Hiroyuki Takahashi1, Yoshihiro Murai1, Zhengguo Cui1, Kazuhiro Nomoto1, Shigeharu Miwa1,2, Koichi Tsuneyama1, Yasuo Takano1

1 Department of Pathology School of Medicine, University of Toyama, Toyama, Japan
2 The third Department of Internal Medicine, School of Medicine, University of Toyama, Toyama, Japan

Correspondence to:
Professor Y Takano
Department of Pathology, School of Medicine, University of Toyama, Sugitani 2630, Toyama, Japan; ytakano{at}ms.toyama-mpu.ac.jp

Aim: To investigate the pathobiological features of intestinal and diffuse-type gastric carcinomas in the Japanese population.

Methods: The expression of fragile histine triad (FHIT), phosphatase and tensin homology deleted from human chromosome 10 (PTEN), caspase-3, Ki-67, mutant p53, matrix metalloproteinase (MMP)-2, MMP-9, and extracellular matrix metalloproteinase inducer (EMMPRIN) on tissue microarrays of gastric carcinomas by immunostaining was examined in comparison with the clinicopathological characteristics between intestinal and diffuse-type cases.

Results: Intestinal-type carcinoma frequently occurred in old men, whereas the diffuse type comparatively occurred more in young women (p<0.05). The diffuse-type carcinoma was more inclined to invasion into muscularis propria, lymphatic invasion and lymph node metastasis, and belonged to higher International Union against Cancer (UICC) staging (p<0.05) compared with intestinal-type counterparts. Expression of FHIT, PTEN, Ki-67, caspase-3, mutant p53 and EMPPRIN was higher in intestinal-type carcinomas than in diffuse-type carcinomas (p<0.05). Kaplan–Meier analysis indicated that patients with intestinal-type carcinomas had a higher cumulative survival rate (p<0.05).

Conclusion: Intestinal-type gastric carcinomas with a more favourable prognosis frequently show high levels of proliferation and apoptosis, and always accompany strong expression of FHIT, PTEN and mutant p53 and EMMPRIN. EMMPRIN expression might underlie the molecular basis of liver metastasis and higher proliferation of intestinal-type gastric carcinomas in Japan. Lauren’s classification thus proved pathologically relevant for the clinical treatment of gastric carcinomas.

Abbreviations: EMMPRIN, extracellular matrix metalloproteinase inducer; FHIT, fragile histine triad; MMP, matrix metalloproteinase; PTEN, phosphatase and tensin homology deleted from human chromosome 10; SRC, signet ring cell carcinoma; TMA, tissue microarray; TSG, tumour suppressor gene; WHO, World Health Organization


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Hou, Q., Wu, Y. H., Grabsch, H., Zhu, Y., Leong, S. H., Ganesan, K., Cross, D., Tan, L. K., Tao, J., Gopalakrishnan, V., Tang, B. L., Kon, O. L., Tan, P. (2008). Integrative Genomics Identifies RAB23 as an Invasion Mediator Gene in Diffuse-Type Gastric Cancer. Cancer Res. 68: 4623-4630 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs